---
layout: default
title: EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment
---

# EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment

**arXiv**: [2512.14019v1](https://arxiv.org/abs/2512.14019) | [PDF](https://arxiv.org/pdf/2512.14019.pdf)

**‰ΩúËÄÖ**: Juseung Yun, Sunwoo Yu, Sumin Ha, Jonghyun Kim, Janghyeon Lee, Jongseong Jang, Soonyoung Lee

**ÂàÜÁ±ª**: cs.LG, q-bio.QM

**ÂèëÂ∏ÉÊó•Êúü**: 2025-12-16

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

<<<<<<< HEAD
**ÊèêÂá∫EXAONE Path 2.5ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÈÄöËøáÂ§öÁªÑÂ≠¶ÂØπÈΩêËß£ÂÜ≥ÁôåÁóáËøõÂ±ï‰∏≠Â§öÁîüÁâ©Â±Ç‰∫§‰∫íÂª∫Ê®°‰∏çË∂≥ÁöÑÈóÆÈ¢ò**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **Âº∫ÂåñÂ≠¶‰π†**

**ÂÖ≥ÈîÆËØç**: `ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°Âûã` `Â§öÊ®°ÊÄÅÂØπÈΩê` `Â§öÁªÑÂ≠¶Êï¥Âêà` `ÂØπÊØîÂ≠¶‰π†` `ÂÖ®ÂàáÁâáÂõæÂÉèÂàÜÊûê` `Á≤æÂáÜËÇøÁò§Â≠¶` `Á©∫Èó¥ÁºñÁ†Å` `ÁîüÁâ©Â≠¶ÂµåÂÖ•`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Ê†∏ÂøÉÈóÆÈ¢òÔºöÁé∞ÊúâÁóÖÁêÜÂ≠¶Ê®°Âûã‰∏ªË¶Å‰æùËµñÂõæÂÉèÊ®°ÊÄÅÔºåÈöæ‰ª•ÊçïÊçâÁôåÁóáËøõÂ±ï‰∏≠Ë∑®ÂàÜÂ≠êÂ±ÇÁöÑ‰∫§‰∫íÔºåÂØºËá¥ÂØπËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÁêÜËß£‰∏çÂÖ®Èù¢„ÄÇ
2. ÊñπÊ≥ïË¶ÅÁÇπÔºöÊèêÂá∫Â§öÊ®°ÊÄÅÂØπÈΩêÊ°ÜÊû∂ÔºåÊï¥ÂêàÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑ„ÄÅË°®ËßÇÈÅó‰º†ÂíåËΩ¨ÂΩïÁªÑÊï∞ÊçÆÔºåÈÄöËøáÂØπÊØîÂ≠¶‰π†Âíå‰∏ìÁî®ÁºñÁ†ÅÊ®°ÂùóÂÆûÁé∞Á®≥ÂÅ•Ë°®ÂæÅ„ÄÇ
3. ÂÆûÈ™åÊàñÊïàÊûúÔºöÂú®Patho-BenchÂü∫ÂáÜ‰∏äËææÂà∞SOTAÊÄßËÉΩÔºåÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆ‰∏≠ÈÄÇÂ∫îÊÄßÊúÄÈ´òÔºåÂ±ïÁ§∫È´òÊï∞ÊçÆÊïàÁéá„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ÁôåÁóáËøõÂ±ïÊ∫ê‰∫éÂ§ö‰∏™ÁîüÁâ©Â±Ç‰πãÈó¥ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÁâπÂà´ÊòØË∂ÖË∂äÂΩ¢ÊÄÅÂ≠¶Âπ∂Ê∂âÂèäÂàÜÂ≠êÂ±ÇÔºåËøô‰∫õÂØπ‰ªÖÂü∫‰∫éÂõæÂÉèÁöÑÊ®°ÂûãÊòØ‰∏çÂèØËßÅÁöÑ„ÄÇ‰∏∫‰∫ÜÊçïÊçâÊõ¥ÂπøÊ≥õÁöÑÁîüÁâ©Â≠¶ÂõæÊôØÔºåÊàë‰ª¨ÊèêÂá∫‰∫ÜEXAONE Path 2.5ÔºåËøôÊòØ‰∏Ä‰∏™ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÈÅó‰º†Â≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Ê®°ÊÄÅÔºåÁîüÊàê‰∏Ä‰∏™Êõ¥ÂÖ®Èù¢ÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÊï¥ÂêàÊÇ£ËÄÖË°®ÂæÅ„ÄÇÊàë‰ª¨ÁöÑÊñπÊ≥ïÂåÖÂê´‰∏â‰∏™ÂÖ≥ÈîÆÁªÑ‰ª∂Ôºö(1) Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÔºåÂÆûÁé∞Ë∑®ÂºÇË¥®Ê®°ÊÄÅÁöÑÂÖ®ÈÖçÂØπÂØπÊØîÂ≠¶‰π†Ôºõ(2) ÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†Å(F-RoPE)Ê®°ÂùóÔºå‰øùÁïôÂÖ®ÂàáÁâáÂõæÂÉè‰∏≠ÁöÑÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÊãìÊâëÔºõ(3) ÈíàÂØπÂÖ®ÂàáÁâáÂõæÂÉèÂíåRNA-seqÁöÑÈ¢ÜÂüü‰∏ìÁî®ÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºå‰∏∫Á®≥ÂÅ•ÁöÑÂ§öÊ®°ÊÄÅÂØπÈΩêÊèê‰æõÂü∫‰∫éÁîüÁâ©Â≠¶ÁöÑÂµåÂÖ•„ÄÇÊàë‰ª¨Âú®‰∏§‰∏™‰∫íË°•Âü∫ÂáÜ‰∏äËØÑ‰º∞EXAONE Path 2.5Ôºö‰∏Ä‰∏™ÂÜÖÈÉ®ÁúüÂÆû‰∏ñÁïå‰∏¥Â∫äÊï∞ÊçÆÈõÜÂíåË¶ÜÁõñ80‰∏™‰ªªÂä°ÁöÑPatho-BenchÂü∫ÂáÜ„ÄÇÊàë‰ª¨ÁöÑÊ°ÜÊû∂Â±ïÁ§∫‰∫ÜÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåÂú®Patho-Bench‰∏äËææÂà∞‰∏éÊúÄÂÖàËøõÂü∫Á°ÄÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂêåÊó∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äËÆæÁΩÆ‰∏≠Ë°®Áé∞Âá∫ÊúÄÈ´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇËøô‰∫õÁªìÊûúÁ™ÅÂá∫‰∫ÜÁîüÁâ©Â≠¶‰ø°ÊÅØÂ§öÊ®°ÊÄÅËÆæËÆ°ÁöÑ‰ª∑ÂÄºÔºåÂπ∂Âº∫Ë∞É‰∫ÜÊï¥ÂêàÂü∫Âõ†ÂûãÂà∞Ë°®ÂûãÂª∫Ê®°ÂØπ‰∏ã‰∏Ä‰ª£Á≤æÂáÜËÇøÁò§Â≠¶ÁöÑÊΩúÂäõ„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöÁôåÁóáËøõÂ±ïÊ∂âÂèäÂ§öÁîüÁâ©Â±Ç‰∫§‰∫íÔºå‰ΩÜÁé∞ÊúâÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°Âûã‰∏ªË¶ÅÂü∫‰∫éÂõæÂÉèÊ®°ÊÄÅÔºåÊó†Ê≥ïÊúâÊïàÊï¥ÂêàÂàÜÂ≠êÊï∞ÊçÆÂ¶ÇÂü∫Âõ†ÁªÑÂíåËΩ¨ÂΩïÁªÑÔºåÂØºËá¥ÂØπËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑË°®ÂæÅ‰∏çÂÆåÊï¥ÔºåÈôêÂà∂‰∫ÜÁ≤æÂáÜËÇøÁò§Â≠¶ÁöÑÂ∫îÁî®„ÄÇÁé∞ÊúâÊñπÊ≥ïÁöÑÁóõÁÇπÂú®‰∫éÊ®°ÊÄÅÂºÇË¥®ÊÄßÈ´ò„ÄÅÁ©∫Èó¥ÁªìÊûÑÂ§çÊùÇÔºå‰ª•ÂèäÁº∫‰πèÁîüÁâ©Â≠¶Âü∫Á°ÄÁöÑÂµåÂÖ•ÂØπÈΩê„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöÈÄöËøáÂ§öÊ®°ÊÄÅÂØπÈΩêÊ°ÜÊû∂ÔºåÂ∞ÜÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑ„ÄÅË°®ËßÇÈÅó‰º†ÂíåËΩ¨ÂΩïÁªÑÊï∞ÊçÆËÅîÂêàÂª∫Ê®°ÔºåÁîüÊàêÊï¥ÂêàÁöÑÊÇ£ËÄÖË°®ÂæÅÔºå‰ª•Êõ¥ÂÖ®Èù¢Âú∞ÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶„ÄÇËÆæËÆ°Âü∫‰∫éÂØπÊØîÂ≠¶‰π†Âíå‰∏ìÁî®ÁºñÁ†ÅÊ®°ÂùóÔºåÁ°Æ‰øùË∑®Ê®°ÊÄÅ‰ø°ÊÅØÊúâÊïàËûçÂêàÔºåÂêåÊó∂‰øùÁïôÂÖ≥ÈîÆÁ©∫Èó¥ÂíåÁîüÁâ©Â≠¶ÁâπÂæÅ„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöÊï¥‰ΩìÊû∂ÊûÑÂåÖÊã¨Êï∞ÊçÆÈ¢ÑÂ§ÑÁêÜ„ÄÅÂ§öÊ®°ÊÄÅÁºñÁ†Å„ÄÅÂØπÈΩêËÆ≠ÁªÉÂíåËØÑ‰º∞Èò∂ÊÆµ„ÄÇ‰∏ªË¶ÅÊ®°ÂùóÊúâÔºöÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±Áî®‰∫éÂÖ®ÈÖçÂØπÂØπÊØîÂ≠¶‰π†ÔºåF-RoPEÊ®°ÂùóÂ§ÑÁêÜÂÖ®ÂàáÁâáÂõæÂÉèÁöÑÁ©∫Èó¥ÁªìÊûÑÔºå‰ª•ÂèäÈ¢ÜÂüü‰∏ìÁî®Âü∫Á°ÄÊ®°Âûã‰∏∫ÂÖ®ÂàáÁâáÂõæÂÉèÂíåRNA-seqÊèê‰æõÁîüÁâ©Â≠¶ÂµåÂÖ•„ÄÇÊµÅÁ®ã‰∏äÔºåÂÖàÈÄöËøáÂÜÖÈÉ®Ê®°ÂûãÁîüÊàêÂµåÂÖ•ÔºåÂÜç‰ΩøÁî®SigLIPÊçüÂ§±ÂØπÈΩê‰∏çÂêåÊ®°ÊÄÅÔºåÊúÄÂêéËæìÂá∫Êï¥ÂêàË°®ÂæÅÁî®‰∫é‰∏ãÊ∏∏‰ªªÂä°„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöÊúÄÈáçË¶ÅÁöÑÊäÄÊúØÂàõÊñ∞ÊòØÂºïÂÖ•Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÂÆûÁé∞Ë∑®ÂºÇË¥®Ê®°ÊÄÅÁöÑÂØπÊØîÂ≠¶‰π†Ôºå‰ª•ÂèäF-RoPEÊ®°Âùó‰øùÁïôÂÖ®ÂàáÁâáÂõæÂÉè‰∏≠ÁöÑÁ©∫Èó¥ÊãìÊâë„ÄÇ‰∏éÁé∞ÊúâÊñπÊ≥ïÁöÑÊú¨Ë¥®Âå∫Âà´Âú®‰∫éÊï¥Âêà‰∫ÜÂ§öÁªÑÂ≠¶Êï∞ÊçÆÔºåËÄåÈùû‰ªÖ‰æùËµñÂõæÂÉèÔºåÂπ∂ÈÄöËøáÁîüÁâ©Â≠¶‰∏ìÁî®Ê®°ÂûãÊèêÂçáÂØπÈΩêÁöÑÁ®≥ÂÅ•ÊÄß„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöÂÖ≥ÈîÆÂèÇÊï∞ËÆæÁΩÆÂåÖÊã¨ÂØπÊØîÂ≠¶‰π†‰∏≠ÁöÑÊ∏©Â∫¶ÂèÇÊï∞ÂíåÊâπÊ¨°Â§ßÂ∞èÔºåÊçüÂ§±ÂáΩÊï∞‰ΩøÁî®SigLIPÂèò‰Ωì‰ºòÂåñË∑®Ê®°ÊÄÅÁõ∏‰ººÊÄß„ÄÇÁΩëÁªúÁªìÊûÑÊ∂âÂèäTransformerÁºñÁ†ÅÂô®Â§ÑÁêÜÂ§öÊ®°ÊÄÅËæìÂÖ•ÔºåF-RoPEÊ®°ÂùóÈõÜÊàêÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†Å‰ª•ÊçïÊçâÁªÑÁªáÁâáÊÆµÂÖ≥Á≥ª„ÄÇÊäÄÊúØÁªÜËäÇËøòÂåÖÊã¨‰ΩøÁî®È¢ÑËÆ≠ÁªÉÁöÑÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÂàùÂßãÂåñÂµåÂÖ•Ôºå‰ª•ÂèäÂ§ö‰ªªÂä°ËÆ≠ÁªÉÁ≠ñÁï•ÊèêÂçáÊ≥õÂåñËÉΩÂäõ„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

Âú®Patho-BenchÂü∫ÂáÜ‰∏äË¶ÜÁõñ80‰∏™‰ªªÂä°ÔºåEXAONE Path 2.5ËææÂà∞‰∏éÊúÄÂÖàËøõÂü∫Á°ÄÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂÖ∑‰ΩìÊèêÂçáÂπÖÂ∫¶Êú™Áü•„ÄÇÂú®ÂÜÖÈÉ®ÁúüÂÆû‰∏ñÁïå‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏≠ÔºåÂ±ïÁ§∫ÊúÄÈ´òÈÄÇÂ∫îÊÄßÔºåË°®ÊòéÊ®°ÂûãÂú®Â§çÊùÇÂú∫ÊôØ‰∏ãÁöÑÁ®≥ÂÅ•ÊÄß„ÄÇÂÆûÈ™åËøòÈ™åËØÅ‰∫ÜÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåÊîØÊåÅËµÑÊ∫êÊúâÈôêÁéØÂ¢É‰∏ãÁöÑÈÉ®ÁΩ≤„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ËØ•Á†îÁ©∂Âú®Á≤æÂáÜËÇøÁò§Â≠¶È¢ÜÂüüÊúâÂπøÊ≥õÂ∫îÁî®ÊΩúÂäõÔºåÂèØÁî®‰∫éÁôåÁóáËØäÊñ≠„ÄÅÈ¢ÑÂêéÈ¢ÑÊµãÂíåÊ≤ªÁñóÂìçÂ∫îËØÑ‰º∞„ÄÇÈÄöËøáÊï¥ÂêàÂ§öÁªÑÂ≠¶Êï∞ÊçÆÔºåËÉΩÊõ¥ÂáÜÁ°ÆÂú∞Ë°®ÂæÅËÇøÁò§ÂºÇË¥®ÊÄßÔºåÊîØÊåÅ‰∏™ÊÄßÂåñÂåªÁñóÂÜ≥Á≠ñ„ÄÇÊú™Êù•ÂèØËÉΩÊé®Âä®‰∏ã‰∏Ä‰ª£ÁóÖÁêÜÂ≠¶Â∑•ÂÖ∑ÂºÄÂèëÔºåÊèêÂçá‰∏¥Â∫äÂÆûË∑µ‰∏≠ÁöÑÁôåÁóáÁÆ°ÁêÜÊïàÁéá„ÄÇ
=======
**ÊèêÂá∫EXAONE Path 2.5ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÈÄöËøáÂ§öÁªÑÂ≠¶ÂØπÈΩêËß£ÂÜ≥ÁôåÁóáÂ§öÊ®°ÊÄÅÂª∫Ê®°‰∏çË∂≥ÈóÆÈ¢ò**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **Âº∫ÂåñÂ≠¶‰π†**

**ÂÖ≥ÈîÆËØç**: `ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°Âûã` `Â§öÊ®°ÊÄÅÂØπÈΩê` `Â§öÁªÑÂ≠¶Êï¥Âêà` `ÂØπÊØîÂ≠¶‰π†` `Á≤æÂáÜËÇøÁò§Â≠¶` `ÂÖ®ÂàáÁâáÂõæÂÉèÂàÜÊûê` `ÁîüÁâ©‰ø°ÊÅØÂ≠¶` `ÁôåÁóáÂª∫Ê®°`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Ê†∏ÂøÉÈóÆÈ¢òÔºöÁé∞ÊúâÁóÖÁêÜÂ≠¶Ê®°Âûã‰∏ªË¶Å‰æùËµñÂõæÂÉèÊ®°ÊÄÅÔºåÈöæ‰ª•ÊçïÊçâÁôåÁóáËøõÂ±ï‰∏≠Ë∑®ÂàÜÂ≠êÂ±ÇÈù¢ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÂØºËá¥ÂØπËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÁêÜËß£‰∏çÂÖ®Èù¢„ÄÇ
2. ÊñπÊ≥ïË¶ÅÁÇπÔºöÊèêÂá∫EXAONE Path 2.5ÔºåÊï¥ÂêàÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑÂ≠¶Á≠âÂ§öÊ®°ÊÄÅÊï∞ÊçÆÔºåÈÄöËøáÂ§öÊ®°ÊÄÅÂØπÈΩêÂíå‰∏ìÁî®ÁºñÁ†ÅÊ®°ÂùóÁîüÊàêÁªºÂêàÊÇ£ËÄÖË°®ÂæÅ„ÄÇ
3. ÂÆûÈ™åÊàñÊïàÊûúÔºöÂú®Patho-BenchÂü∫ÂáÜ‰∏äËææÂà∞ÊúÄÂÖàËøõÊÄßËÉΩÔºåÂú®‰∏¥Â∫äÊï∞ÊçÆ‰∏≠Â±ïÁ§∫È´òÈÄÇÂ∫îÊÄßÔºåÈ™åËØÅ‰∫ÜÂ§öÁªÑÂ≠¶Âª∫Ê®°ÁöÑÊúâÊïàÊÄß„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ÁôåÁóáËøõÂ±ïÊ∫ê‰∫éÂ§ö‰∏™ÁîüÁâ©Â±ÇÈù¢ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÁâπÂà´ÊòØË∂ÖË∂äÂΩ¢ÊÄÅÂ≠¶‰∏îÊ∂âÂèäÂàÜÂ≠êÂ±ÇÈù¢ÔºåËøô‰∫õÂØπ‰ªÖÂü∫‰∫éÂõæÂÉèÁöÑÊ®°ÂûãÊòØ‰∏çÂèØËßÅÁöÑ„ÄÇ‰∏∫ÊçïÊçâÊõ¥ÂπøÊ≥õÁöÑÁîüÁâ©ÊôØËßÇÔºåÊàë‰ª¨ÊèêÂá∫‰∫ÜEXAONE Path 2.5ÔºåËøôÊòØ‰∏Ä‰∏™ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÈÅó‰º†Â≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Ê®°ÊÄÅÔºåÁîüÊàêÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶Êõ¥ÂÖ®Èù¢ÁöÑÊï¥ÂêàÊÇ£ËÄÖË°®ÂæÅ„ÄÇÊàë‰ª¨ÁöÑÊñπÊ≥ïÂåÖÂê´‰∏â‰∏™ÂÖ≥ÈîÆÁªÑ‰ª∂Ôºö(1) Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÔºåÂÆûÁé∞Ë∑®ÂºÇË¥®Ê®°ÊÄÅÁöÑÂÖ®ÈÖçÂØπÂØπÊØîÂ≠¶‰π†Ôºõ(2) ÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†Å(F-RoPE)Ê®°ÂùóÔºå‰øùÁïôÂÖ®ÂàáÁâáÂõæÂÉè‰∏≠ÁöÑÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÊãìÊâëÔºõ(3) ÈíàÂØπÂÖ®ÂàáÁâáÂõæÂÉèÂíåRNA-seqÁöÑÈ¢ÜÂüü‰∏ìÁî®ÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºåÊèê‰æõÂü∫‰∫éÁîüÁâ©Â≠¶ÁöÑÂµåÂÖ•Ôºå‰ª•ÂÆûÁé∞Á®≥ÂÅ•ÁöÑÂ§öÊ®°ÊÄÅÂØπÈΩê„ÄÇÊàë‰ª¨Âú®‰∏§‰∏™‰∫íË°•Âü∫ÂáÜ‰∏äËØÑ‰º∞EXAONE Path 2.5‰∏éÂÖ≠‰∏™È¢ÜÂÖàÁöÑÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºö‰∏Ä‰∏™ÂÜÖÈÉ®ÁúüÂÆû‰∏ñÁïå‰∏¥Â∫äÊï∞ÊçÆÈõÜÂíåË¶ÜÁõñ80‰∏™‰ªªÂä°ÁöÑPatho-BenchÂü∫ÂáÜ„ÄÇÊàë‰ª¨ÁöÑÊ°ÜÊû∂Â±ïÁ§∫‰∫ÜÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåÂú®Patho-Bench‰∏äËææÂà∞‰∏éÊúÄÂÖàËøõÂü∫Á°ÄÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂêåÊó∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äËÆæÁΩÆ‰∏≠Ë°®Áé∞Âá∫ÊúÄÈ´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇËøô‰∫õÁªìÊûúÁ™ÅÊòæ‰∫ÜÂü∫‰∫éÁîüÁâ©Â≠¶ÁöÑÂ§öÊ®°ÊÄÅËÆæËÆ°ÁöÑ‰ª∑ÂÄºÔºåÂπ∂Âº∫Ë∞É‰∫ÜÊï¥ÂêàÂü∫Âõ†ÂûãÂà∞Ë°®ÂûãÂª∫Ê®°ÂØπ‰∏ã‰∏Ä‰ª£Á≤æÂáÜËÇøÁò§Â≠¶ÁöÑÊΩúÂäõ„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

EXAONE Path 2.5ÁöÑÊï¥‰ΩìÊ°ÜÊû∂ÊòØ‰∏Ä‰∏™Â§öÊ®°ÊÄÅÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÊó®Âú®ËÅîÂêàÂ§ÑÁêÜÁªÑÁªáÂ≠¶ÂõæÂÉèÔºàÂ¶ÇÂÖ®ÂàáÁâáÂõæÂÉèÔºâÂíåÂàÜÂ≠êÊï∞ÊçÆÔºàÂ¶ÇÂü∫Âõ†ÁªÑ„ÄÅËΩ¨ÂΩïÁªÑÔºâ„ÄÇÂÖ≥ÈîÆÊäÄÊúØÂàõÊñ∞ÁÇπÂåÖÊã¨Ôºö‰ΩøÁî®Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ËøõË°åË∑®Ê®°ÊÄÅÂØπÊØîÂ≠¶‰π†ÔºåÁ°Æ‰øù‰∏çÂêåÊï∞ÊçÆÁ±ªÂûãÁöÑÊúâÊïàÂØπÈΩêÔºõÂºïÂÖ•ÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†Å(F-RoPE)Ê®°ÂùóÔºå‰ª•‰øùÁïôÂÖ®ÂàáÁâáÂõæÂÉè‰∏≠ÁöÑÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÊãìÊâëÔºõ‰ª•ÂèäÈÉ®ÁΩ≤È¢ÜÂüü‰∏ìÁî®ÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºå‰∏∫ÂÖ®ÂàáÁâáÂõæÂÉèÂíåRNA-seqÊèê‰æõÁîüÁâ©Â≠¶Âü∫Á°ÄÁöÑÂµåÂÖ•„ÄÇ‰∏éÁé∞ÊúâÊñπÊ≥ïÁöÑ‰∏ªË¶ÅÂå∫Âà´Âú®‰∫éÂÖ∂Âº∫Ë∞ÉÂ§öÁªÑÂ≠¶ÂØπÈΩêÔºåÈÄöËøáÊï¥ÂêàÂ§öÁßçÁîüÁâ©Ê®°ÊÄÅÊù•Êõ¥ÂÖ®Èù¢Âú∞Âª∫Ê®°ËÇøÁò§ÁîüÁâ©Â≠¶ÔºåËÄå‰º†ÁªüÊñπÊ≥ïÈÄöÂ∏∏Â±ÄÈôê‰∫éÂçï‰∏ÄÊ®°ÊÄÅÊàñÁÆÄÂçïËûçÂêà„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

Âú®Patho-BenchÂü∫ÂáÜÊµãËØï‰∏≠ÔºåEXAONE Path 2.5ËææÂà∞‰∏éÊúÄÂÖàËøõÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåË¶ÜÁõñ80‰∏™‰ªªÂä°ÔºõÂú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏äÂ±ïÁ§∫ÊúÄÈ´òÈÄÇÂ∫îÊÄßÔºåÈ™åËØÅ‰∫ÜÂÖ∂È´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåÁ™ÅÊòæÂ§öÊ®°ÊÄÅÂØπÈΩêÁöÑ‰ºòÂäø„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ËØ•Á†îÁ©∂Âú®Á≤æÂáÜËÇøÁò§Â≠¶È¢ÜÂüüÂÖ∑ÊúâÈáçË¶ÅÂ∫îÁî®‰ª∑ÂÄºÔºåÂèØÁî®‰∫éÁôåÁóáËØäÊñ≠„ÄÅÈ¢ÑÂêéÈ¢ÑÊµãÂíåÊ≤ªÁñóÂìçÂ∫îÂàÜÊûê„ÄÇÈÄöËøáÊï¥ÂêàÂ§öÊ®°ÊÄÅÊï∞ÊçÆÔºåÊ®°ÂûãËÉΩÊèê‰æõÊõ¥ÂÖ®Èù¢ÁöÑÊÇ£ËÄÖË°®ÂæÅÔºåÊîØÊåÅ‰∏™ÊÄßÂåñÂåªÁñóÂÜ≥Á≠ñÔºåÊé®Âä®‰∏ã‰∏Ä‰ª£ÁôåÁóáÁ†îÁ©∂Âíå‰∏¥Â∫äÂÆûË∑µÁöÑÂèëÂ±ï„ÄÇ
>>>>>>> 1c05e1c356e1f28c2e5e6e14cf6811c0d5120ab7

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Cancer progression arises from interactions across multiple biological layers, especially beyond morphological and across molecular layers that remain invisible to image-only models. To capture this broader biological landscape, we present EXAONE Path 2.5, a pathology foundation model that jointly models histologic, genomic, epigenetic and transcriptomic modalities, producing an integrated patient representation that reflects tumor biology more comprehensively. Our approach incorporates three key components: (1) multimodal SigLIP loss enabling all-pairwise contrastive learning across heterogeneous modalities, (2) a fragment-aware rotary positional encoding (F-RoPE) module that preserves spatial structure and tissue-fragment topology in WSI, and (3) domain-specialized internal foundation models for both WSI and RNA-seq to provide biologically grounded embeddings for robust multimodal alignment. We evaluate EXAONE Path 2.5 against six leading pathology foundation models across two complementary benchmarks: an internal real-world clinical dataset and the Patho-Bench benchmark covering 80 tasks. Our framework demonstrates high data and parameter efficiency, achieving on-par performance with state-of-the-art foundation models on Patho-Bench while exhibiting the highest adaptability in the internal clinical setting. These results highlight the value of biologically informed multimodal design and underscore the potential of integrated genotype-to-phenotype modeling for next-generation precision oncology.

